Press Release May 24, 2024 hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based Protein Editing Platform
Press Release May 08, 2024 hC Bioscience Presents Preclinical Data at ASGCT Showing Strong Potential in Hemophilia A Using tRNA-based Protein Editing Platform
Press Release April 23, 2024 hC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing Approach Using Anticodon Engineered tRNA
Press Release October 20, 2023 hC Bioscience Inc. Establishes World Class Oncology Clinical Advisory Board; Expands Medical and Regulatory Team
Press Release September 25, 2023 hC Bioscience Appoints Jose Lora, Ph.D., as Chief Scientific Officer to Lead Development of the Company’s Therapeutic tRNA
Press Release May 24, 2024 hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based Protein Editing Platform
Press Release May 08, 2024 hC Bioscience Presents Preclinical Data at ASGCT Showing Strong Potential in Hemophilia A Using tRNA-based Protein Editing Platform
Press Release April 23, 2024 hC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing Approach Using Anticodon Engineered tRNA
Press Release October 20, 2023 hC Bioscience Inc. Establishes World Class Oncology Clinical Advisory Board; Expands Medical and Regulatory Team
Press Release September 25, 2023 hC Bioscience Appoints Jose Lora, Ph.D., as Chief Scientific Officer to Lead Development of the Company’s Therapeutic tRNA
Press Release September 15, 2023 hC Bioscience Appoints Cindy Driscoll as Senior Vice President of Finance to Lead Expanded Finance Team
Press Release July 18, 2023 hC Bioscience Appoints Heather Hirsch, Ph.D. as SVP of Translational Science and Cancer Biology, Strengthening Leadership Team in Advancing tRNA-Based Therapeutics
Media September 19, 2023 Discussing the science of transfer RNA for protein editing with hCB’s CEO Biotech TV
Publication / Presentation February 10, 2021 Therapeutic promise of engineered nonsense suppressor tRNAs Wiley Interdisciplinary Reviews: RNA
Publication / Presentation February 18, 2019 Engineered transfer RNAs for suppression of premature termination codons Nature Communications